Pharmexcil Urges Indian Pharma Firms to Tap Saudi Market
Pharmexcil is encouraging Indian pharma companies to explore opportunities in Saudi Arabia’s expanding pharmaceutical and specialty chemicals sectors.
A virtual session on June 23, 2025—organized by Saudi Arabia’s Ministry of Investment and the Indian Embassy in Riyadh—will highlight investment prospects, reforms, and incentives in the Kingdom’s healthcare sector.
Saudi Arabia, with the largest pharma market in MENA ($8.6B in 2023, projected $15.21B by 2027), is pushing for local production, creating opportunities for Indian firms strong in generics and biosimilars.
The session includes presentations, a Q&A, and insights into partnerships, R&D, and regulatory processes. The Indian Embassy has assured full support to participating companies.
If you are a fresher in the Business.
Join our Startup Export Training .
For more details.
Visit www.ucorpexim.in or Contact 7598 404848
If you have basic about the Export Business.
Join our Advanced Realtime Export Training.
For more details.
Visit www.ucorpareto.com or Contact 7598 424848
#export #exporter #exportimport #exports #importexport #exportproduct #exportbusiness #exportbag #exportquality #exportindia #exporting #exportimportdata #eximedia #indiaexport #indiaexports #indiaexporters #indiaexportimport #indiabusiness #ucorpexim #exporttraining#exportstraining #exportertraining #exporterstraining #importtraining #importstraining #importertraining #importerstraining #ucorp
share News